Ally Therapeutics - Crunchbase Company Profile & Funding

Q: When was the last funding round for Ally Therapeutics?

Ally Therapeutics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Ally Therapeutics raised to date?

Ally Therapeutics has raised obfuscated.

Overview

Ally Therapeutics

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Ally Therapeutics

Ally Therapeutics solves the immune response barriers for gene therapy.

Closed

Founded

obfuscation

Private

Venture - Series Unknown

Cambridge, Massachusetts, United States

1-10

www.allytx.com/

Biopharma

Biotechnology

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Jessica Chiang: Co-Founder and Principal Scientist

Details

Legal Name

Ally Therapeutics, Inc.

Operating Status

Closed

Company Type

For Profit

Founders

Jessica Chiang, Tina Liu, Ying Chan

About the Company

Ally Therapeutics solves the immune response barriers for gene therapy. They are dedicated to solving the immune response issues that limit the safety and efficacy of in vivo gene therapies. It is backed by ARCH, Alta, and UCB Ventures. The company is a new biotech company based in Cambridge, Massachusetts, and was founded in 2018.

Diversity Spotlight

Women Founded

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ally Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown